Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
20/20 HealthCare Partners LLC is a global investment group founded in 2005 and based in Auburndale, Massachusetts. The firm specializes in early-stage technology and life science innovations that aim to significantly impact healthcare and improve quality of life. By collaborating with entrepreneurs, executives, and strategic partners within the healthcare community, 20/20 HealthCare Partners seeks to build valuable companies that address critical healthcare challenges.
The firm operates with a small team of approximately five professionals and has developed a unique investment model that invites high-net-worth individuals and family offices to invest on a deal-by-deal basis. This approach allows for a flexible investment structure, enabling the firm to capitalize on various market opportunities, particularly in the life sciences sector. 20/20 HealthCare Partners does not raise a pooled fund, instead offering a 6% preferred dividend for limited partners and a 20% carry after the preferred is paid.
As of now, the firm manages a portfolio of eight notable companies, focusing on sectors such as healthcare IT, biotechnology, medical devices, diagnostics, and pharmaceuticals. Their global investment scope, despite being based in Massachusetts, allows them to engage with a diverse range of healthcare innovations.
20/20 HealthCare Partners invests in a diverse array of sectors within healthcare, including diagnostic imaging, medical devices, healthcare IT, biotechnology, and pharmaceuticals. The firm targets early-stage companies, specifically in the pre-seed, seed, and Series A stages, with a flexible investment structure that allows them to adapt to market opportunities. They seek extraordinary entrepreneurs with distinctive technologies that can lead to valuable companies.
The firm emphasizes device and diagnostics innovation with clinical applicability, aiming to support startups that can significantly improve healthcare outcomes. Their investment strategy is designed to address critical healthcare challenges, and they actively seek partnerships with entrepreneurs who share their vision for impactful healthcare solutions. This focus on early-stage investments positions 20/20 HealthCare Partners as a key player in the healthcare technology and life sciences sectors.
20/20 HealthCare Partners has built a notable portfolio of eight companies, each contributing to advancements in healthcare technology and life sciences:
As of the latest updates, 20/20 HealthCare Partners has not reported any recent investments or exits since 2021. The firm maintains a low profile with limited public activity, focusing primarily on its portfolio companies and investment strategy.
Notable past activities include significant investments in companies like Corindus, Inc., which received initial seed funding that enabled the development of a robotic catheterization system. The firm also led follow-on investments in various portfolio companies, demonstrating its commitment to supporting growth within its investments.
What are the investment criteria for 20/20 HealthCare Partners?
The firm invests in early-stage companies within the healthcare sector, focusing on diagnostic imaging, medical devices, healthcare IT, biotechnology, and pharmaceuticals. They seek extraordinary entrepreneurs with distinctive technologies that can lead to valuable companies.
How can I pitch to 20/20 HealthCare Partners?
Founders interested in pitching should prepare a detailed presentation that outlines their technology, market potential, and team qualifications. While specific application forms or portals are not mentioned, direct outreach via their contact information is recommended.
What makes 20/20 HealthCare Partners different from other investors?
The firm operates on a deal-by-deal basis rather than raising a pooled fund, allowing for a flexible investment structure. They offer a 6% preferred dividend for limited partners and a 20% carry after the preferred is paid, which is a unique approach in the venture capital landscape.
What is the geographic scope of 20/20 HealthCare Partners?
20/20 HealthCare Partners has a global investment focus, despite being based in Massachusetts. They are open to opportunities across North America and beyond.
What is the typical check size for investments?
While specific check sizes are not disclosed, the firm invests in early-stage rounds, including pre-seed, seed, and Series A stages, which typically range from hundreds of thousands to several million dollars.
What kind of support do portfolio companies receive?
20/20 HealthCare Partners adds value to its portfolio companies by leveraging its extensive network within the healthcare community, providing strategic guidance, and facilitating partnerships that enhance growth and innovation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.